Wuhan Huakang Century Medical Future Growth
Future criteria checks 5/6
Wuhan Huakang Century Medical is forecast to grow earnings and revenue by 66.2% and 45% per annum respectively while EPS is expected to grow by 65.9% per annum.
Key information
66.2%
Earnings growth rate
65.9%
EPS growth rate
Medical Equipment earnings growth | 24.0% |
Revenue growth rate | 45.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Sep 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 3,690 | 357 | N/A | -346 | 1 |
12/31/2024 | 2,642 | 229 | N/A | -345 | 1 |
3/31/2024 | 1,591 | 93 | -733 | -132 | N/A |
12/31/2023 | 1,602 | 107 | -735 | -187 | N/A |
9/30/2023 | 1,555 | 106 | -816 | -361 | N/A |
6/30/2023 | 1,486 | 109 | -690 | -400 | N/A |
3/31/2023 | 1,298 | 94 | -469 | -355 | N/A |
12/31/2022 | 1,189 | 102 | -467 | -342 | N/A |
9/30/2022 | 1,145 | 106 | -173 | -113 | N/A |
6/30/2022 | 955 | 90 | -30 | 22 | N/A |
3/31/2022 | 913 | 84 | -34 | -10 | N/A |
1/1/2022 | 861 | 81 | 38 | 45 | N/A |
9/30/2021 | 862 | 84 | 83 | 89 | N/A |
6/30/2021 | 786 | 50 | 36 | 40 | N/A |
3/31/2021 | 702 | 36 | 6 | 9 | N/A |
12/31/2020 | 762 | 53 | 81 | 85 | N/A |
12/31/2019 | 602 | 59 | -6 | -4 | N/A |
12/31/2018 | 427 | 30 | -71 | -62 | N/A |
12/31/2017 | 383 | 18 | N/A | -51 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301235's forecast earnings growth (66.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 301235's earnings (66.2% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 301235's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301235's revenue (45% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 301235's revenue (45% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301235's Return on Equity is forecast to be high in 3 years time